Literature DB >> 28131524

The histopathologic type predicts survival of patients with ampullary carcinoma after resection: A meta-analysis.

Yanming Zhou1, Dianqi Li2, Lupeng Wu3, Xiaoying Si3.   

Abstract

OBJECTIVES: The results of studies on the prognostic value of histopathologic differentiation of the intestinal and pancreatobiliary types of ampullary carcinoma after resection are conflicting. A meta-analysis was undertaken to investigate this issue.
METHODS: A systematic literature search was performed to identify articles published from January 2000 to August 2016. Data were pooled for meta-analysis using Review Manager 5.3.
RESULTS: Twenty three retrospective studies involving a total of 2234 patients were identified for inclusion, of whom 1021 (45.7%) had intestinal type tumors and 899 (40.2%) had pancreaticobiliary type tumors. Patients with the pancreaticobiliary type had high rates of poor tumor differentiation (P < 0.001), lymph node metastasis (P < 0.001), vascular invasion (P < 0.001), perineural invasion (P < 0.001), and positive resection margins (P = 0.004), as compared with those with the intestinal type. The pancreaticobiliary type predicted a worse overall survival (hazard ratio [HR] 1.84, 95% CI 1.49-2.27; P < 0.001) and disease-free survival (HR 1.93, 95% CI 1.23-3.01; P = 0.004).
CONCLUSION: The histopathologic type has major impact on survival in patients with ampullary carcinoma after resection, and the pancreaticobiliary type reflects a more aggressive tumor biology and is associated with worse survival.
Copyright © 2017 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ampullary adenocarcinoma; Intestinal; Pancreatobiliary; Prognosis

Mesh:

Year:  2017        PMID: 28131524     DOI: 10.1016/j.pan.2017.01.007

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  5 in total

1.  Association of Adjuvant Therapy with Improved Survival in Ampullary Cancer: A National Cohort Study.

Authors:  Ibrahim Nassour; Linda S Hynan; Alana Christie; Rebecca M Minter; Adam C Yopp; Michael A Choti; John C Mansour; Matthew R Porembka; Sam C Wang
Journal:  J Gastrointest Surg       Date:  2017-11-10       Impact factor: 3.452

2.  Clinical Outcome of Ampullary Carcinoma: Single Cancer Center Experience.

Authors:  Mohammed Al-Jumayli; Amna Batool; Akshay Middiniti; Anwaar Saeed; Weijing Sun; Raed Al-Rajabi; Joaquina Baranda; Sean Kumer; Timothy Schmitt; Anusha Chidharla; Anup Kasi
Journal:  J Oncol       Date:  2019-05-02       Impact factor: 4.375

3.  Intraoperative Pancreatic Ductoscopy for Ampullary Adenocarcinoma During Pancreatic Resection: A Case Report.

Authors:  Anthony Congiusta; Ariel Brown; Andrew M Brown; Charles J Yeo
Journal:  J Pancreat Cancer       Date:  2019-10-10

4.  Preoperative prognostic nutritional index as an independent prognostic factor for resected ampulla of Vater cancer.

Authors:  Young Jin Yoo; Chang Moo Kang; Munseok Choi; Seung Yoon Rho; Ho Kyung Hwang; Woo Jung Lee; Eun Wha Kim; Jin Ae Lee
Journal:  PLoS One       Date:  2020-03-03       Impact factor: 3.240

5.  Very early recurrence following pancreaticoduodenectomy in patients with ampullary cancer.

Authors:  Hyeong Min Park; Sang-Jae Park; Sung-Sik Han; Seong Kweon Hong; Eun Kyung Hong; Sun-Whe Kim
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.